Fresenius Kabi Oncology Ltd. | FKONCO | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
| Chart | 2012 | 2013 | |
|---|---|---|---|
Cash flows from Operations | | | |
Net income |
| 717 | 1,148 |
Depreciation & amortization |
| 240 | 258 |
Investment gain & loss |
| 0 | 0 |
Income taxes |
| 0 | 0 |
Stock based compensation |
| 0 | 0 |
Working capital changes | | | |
Accounts receivable |
| -16 | 249 |
Inventory |
| 187 | -585 |
Accounts payable |
| 577 | 511 |
Other working capital |
| 0 | 0 |
Minority Interest |
| 0 | 0 |
Other items |
| 0 | 0 |
Cash provided by operat... |
| 1,871 | 1,552 |
Income tax paid |
| -128 | -278 |
Net cash generated from op... |
| 1,743 | 1,274 |
Cash flows from Investment | | | |
Investments in PPE |
| -1,124 | -1,210 |
Sale of PPE |
| 18 | 2 |
Purchases of investment |
| 0 | 0 |
Sales/Maturities of investment |
| 1,263 | 0 |
Acquisitions, net |
| 0 | 0 |
Lease Cost |
| 0 | 0 |
Other investing activities |
| 0 | 0 |
Net cash used for Investin... |
| 168 | -1,204 |
Cash Flows From Financing | | | |
Debt issued |
| 0 | 0 |
Debt repayment |
| -1,856 | -72 |
Common stock issued |
| 0 | 0 |
Dividend paid |
| 0 | 0 |
Interest Paid |
| -108 | -125 |
Other financing activities |
| 0 | 0 |
Net cash provided by Finan... |
| -1,965 | -196 |
Others |
| 0 | 0 |
Net change in cash |
| -54 | -126 |
Cash at beginning of period |
| 185 | 131 |
Cash at end of period |
| 131 | 5 |
Free Cash Flow |
| 619 | 64 |